INS and type 2 diabetes mellitus: Misfolding of the insulin prohormone, proinsulin (PI), is increasingly appreciated as an early pathogenic event in type 2 diabetes (T2D) when a mismatch is reached between PI biosynthetic demand, typically increased due to insulin resistance, and folding capacity [1,2].